Table 1C.
Country (region) | Population (in millions) | COVID-19 cases per million (in thousands) | Deaths due to COVID-19 (per million) |
Wave with more impact on the country | Wave with more impact on NBS | Average number of newborns per country (2015–2020; from 30 June of the initial and final year) | Newborns screened/year/centre | Number of diseases in NBS | Impairment of NBS during the pandemic* | Were there plans/guidelines for NBS during a pandemic |
MENA region | ||||||||||
Jordan (Irbid) | 10.3 | 69.3 | 865 | Second | Second | 214 646 | 200 | 11–20 | A lot | No |
Kuwait | 4.3 | 63.9 | 365 | Second | Second | 58 281 | 60 000 | 21–30 | Little | Yes |
Lebanon (Lebanon) | 6.8 | 77.7 | 1077 | Second | Second | 117 336 | 20 000 | 21–30 | Moderate | No |
Pakistan (Sindh) | 224.5 | 3.7 | 81 | Second | Second | 5 994 075 | 6000 | 1–5 | Little | No |
Saudi Arabia | 35.3 | 11.9 | 198 | N/A | N/A | 599 706 | N/A | N/A | N/A | N/A |
*A 5-point Likert scale was used to determine the impairment (1=none, 2=little, 3=moderate, 4=a lot, 5=a great deal).
MENA, Middle East and North Africa; N/A, not available; NBS, newborn screening.